Literature DB >> 6831291

The antiarrhythmic effects of verapamil and propranolol in aminophylline toxic dogs.

R M Friesen, J F Bonet.   

Abstract

The antiarrhythmic effects of the calcium blocker verapamil and the beta adrenoreceptor blocker propranolol were examined in aminophylline toxic dogs. Eighteen dogs were intubated and ventilated after induction of anaesthesia (pentobarbitone 30 mg/kg and paccuronium 0.1 mg/kg). All animals were rendered toxic by aminophylline infusion; an initial dose of 50 mg/kg over five minutes with subsequent doses of 10 mg/kg over 30 seconds. Twenty minutes after each aminophylline infusion, the dog was challenged with phenylephrine (10 to 20 micrograms/kg). This resulted in short duration hypertension and reproducible emergence of ventricular arrhythmias. The dogs were divided into three groups of six animals each. Group I (control) received no antiarrhythmics whereas Group II received verapamil 0.2 mg/kg and Group III received propranolol 0.1 mg/kg for the treatment of persistent ventricular arrhythmias. Both verapamil and propranolol exerted an antiarrhythmic effect in aminophylline induced ventricular arrhythmias. The efficacy of verapamil was independent of the accompanying reduction in blood pressure and systemic vascular resistance as subsequent phenylephrine induced hypertension could not reinstitute these arrhythmias. Propranolol appeared less effective since it did not completely suppress the arrhythmias in three dogs and could not prevent emergence of PVC's in four following repeat phenylephrine challenge. Further development of this animal model may be useful for the better understanding of ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831291     DOI: 10.1007/bf03009340

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  9 in total

1.  Effects of cardiotoxic doses of adrenergic amines on myocardial cyclic AMP.

Authors:  R G Blaiklock; E M Hirsh; D Lehr
Journal:  J Mol Cell Cardiol       Date:  1978-05       Impact factor: 5.000

Review 2.  Aminophylline.

Authors:  J A Stirt; S F Sullivan
Journal:  Anesth Analg       Date:  1981-08       Impact factor: 5.108

Review 3.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.

Authors:  P H Stone; E M Antman; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

4.  Massive theophylline overdose. Rapid elimination by charcoal hemoperfusion.

Authors:  S M Ehlers; D E Zaske; R J Sawchuk
Journal:  JAMA       Date:  1978-08-04       Impact factor: 56.272

5.  Concentration of myocardial cyclic AMP and ventricular fibrillation induced by aminophylline.

Authors:  M Sugiura; K Ogawa; N Yamazaki
Journal:  Jpn Heart J       Date:  1979-03

6.  Epinephrine-induced arrhythmias and cardiovascular function after verapamil during halothane anesthesia in the dog.

Authors:  P A Kapur; W E Flacke
Journal:  Anesthesiology       Date:  1981-09       Impact factor: 7.892

7.  Acute blood pressure elevation and ventricular fibrillation threshold during coronary occlusion and reperfusion in the dog.

Authors:  C M Blatt; R L Verrier; B Lown
Journal:  Am J Cardiol       Date:  1977-04       Impact factor: 2.778

8.  Arrhythmogenic effects of aminophylline during halothane anesthesia in experimental animals.

Authors:  J A Stirt; J M Berger; S M Ricker; S F Sullivan
Journal:  Anesth Analg       Date:  1980-06       Impact factor: 5.108

9.  Valsalva termination of ventricular tachycardia.

Authors:  M B Waxman; R W Wald; J P Finley; J F Bonet; E Downar; A D Sharma
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.